Skip to content
NECS Medicines Optimisation. A care system support organisation
  • Home
  • Formularies & Guidelines
  • Practice, PCN & Care Home Resources
  • Patient Group Directions
  • NECS good practice guidance and tools for care homes
  • Controlled Drugs
    1. Home
    2. Memos and Alerts
    3. Jext Adrenaline Auto-Injectors – Extended Use By Dates

    Back to   Home

    Jext Adrenaline Auto-Injectors – Extended Use By Dates

    Posted on: 17th October 201817th October 2018

    The MHRA have authorised ALK to extend the use by dates of specified Lots (Batches) of Jext 150 microgram adrenaline auto-injectors & Jext 300 microgram adrenaline auto-injectors (follow links for Lot/Batch numbers).

    Please see the JEXT website and DHSC Q&A for full details.

    Posted in Memos and Alerts, News, Supply Issues_Shortages

    • Previous : Adrenaline 150microgram Auto-injectors – Supply Controls
    • Next : Gabapentin & Pregabalin – to be Controlled Drugs in 2019

    Support links

    • Accessibility statement
    • Terms of Use
    • Contact Us
    • Cookie and Privacy Policy

    © Copyright, NECS Medicines Optimisation 2024